Diligence memo · auto-generated · as of July 2, 2026
KelSie Biotech Corp
KelSie Biotech Corp looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
KelSie Biotech Corp operates in Biotech, based in ENGLEWOOD.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
KelSie Biotech Corp has raised $3.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.0M on 2019-05-17.
Most recent recorded round closed around 2021-03-19.
Valuation (modeled)modeled
Provath models KelSie Biotech Corp at approximately $40M (range $969K–$261M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.46× the median modeled value of Seed Biotech companies in 2019–2021 (7 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 22 months.
Last raise 5.3 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 77% of Biotech peers (233 compared).
Modeled value ranks above 80% of those peers.
Closest niche peers: Orpheus Bioscience, Inc., OneThree Biotech, Inc., Phloem Biotech, Inc., Meridian Biotech, LLC, Sixfold Bioscience Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.